Utilità Del Dosaggio Dell'Idrossiprolina Urinaria Nella Valutazione Della Risposta Alla Terapia Del Carcinoma Prostatico in Stadio Avanzato

Bishop M. C. , Fellow G. J. : Urine hydroxyproline excretion - a marker of bone metastases in prostatic carcinoma. Brit. J. Urol., 49; 711–716 (1977).

Bonadonna G. , Merlino M. S. , Hyers W. P. , Sonenberg M. : Urinary hydroxyproline and calcium metabolism in patients with cancer. N. Engl. J. Med., 275; 298 (1966).

Henneberry M. O. , Engel G. , Grayhack J. T. : Acid phosphatase. Urol. Clin. N. Amer., 6; 629 (1979).

Hopkin S. C. , Palmieri G. , Niell H. , Moinuddin M. , Soloway M. : Total and nondializable hydroxyproline excretion in stage D₂ prostate cancer. Cancer, 53; 117–121 (1984).

Hopkins S. C. , Nissekorn J. , Palmieri G. M. , Ikard M. , Moinuddin M. , Soloway M. S. : Serial spot hydroxyproline/creatinine ratios in metastatic prostatic cancer. J. Urol., 129; 319–323 (1983).

Mooppan M. M. , Wax S. H. , Kim H. , Wang J. C. , Tobin M. S. : Urinary hydroxyproline excretion as a marker of osseous metastasis in carcinoma of the prostate. J. Urol., 123; 694 (1980).

Mundy A. R. : Urinary hydroxyproline excretion in carcinoma of the prostate. A comparison of 4 different modes of assessment and its role as a marker. Brit. J. Urol., 51; 570 (1979).

Niell H. B. , Palmier G. M. , Neely C. L. , McDonald M. W. : Postabsorptive urinary hydroxyproline (spot-HYPRO) in patients with multiple myeloma. Cancer, 48; 783 (1981).

Konturi M. J. , Sotameni E. A. , Larmi T. K. I. : Hydroxyproline in early diagnosis of bone metastases in prostatic cancer. Scand. J. Urol. Nephrol., 8; 91–95 (1974).

Pollen J. J. , Gerber K. , Ashburn W. L. , Schmidt J. D. : The value of nuclear bone imagining in advanced prostatic cancer. J. Urol., 125; 222 (1981).

Powles T. J. , Leese C. L. , Bondy P. K. : Hydroxyproline excretion in patients with breast cancer and response to treatment. Brit. Med. J., 2; 164 (1975).

Romics T. , Lang Yel L. : Study of serum and urine hydroxyproline level of patients with prostatic cancer. Eur. Urol., 10; 395–397 (1984).

Waysman Z. , Chu T. M. , Bross D. , Saroff Y. , Murphy G. P. , Johnnson D. E. , Scott W. W. , Gibbons R. P. , Pront G. R. , Schimdt J. D. : Clinical significance of serum alkaline phosphatase isoenzyme levels in advanced prostatic carcinoma. J. Urol., 199; 244 (1978).